3,788
Views
13
CrossRef citations to date
0
Altmetric
Research Articles

Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: in vitro and in vivo evaluation

ORCID Icon, , , , , , , & show all
Pages 111-127 | Received 02 Nov 2021, Accepted 13 Dec 2021, Published online: 29 Dec 2021

References

  • Al-Dosari DI, Ahmed MM, Al-Rejaie SS, et al. (2017). Flavonoid naringenin attenuates oxidative stress, apoptosis and improves neurotrophic effects in the diabetic rat retina. Nutrients 9:1161.
  • Alkholief M, Albasit H, Alhowyan A, et al. (2019). Employing a PLGA-TPGS based nanoparticle to improve the ocular delivery of acyclovir. Saudi Pharm J 27:293–302.
  • Baspinar Y, Bertelmann E, Pleyer U, et al. (2008). Corneal permeation studies of everolimus microemulsion. J Ocul Pharmacol Ther 24:399–402.
  • Bhia M, Motallebi M, Abadi B, et al. (2021). Naringenin nano-delivery systems and their therapeutic applications. Pharmaceutics 13:291.
  • Chang Y, Zhai L, Peng J, et al. (2021). Phytochemicals as regulators of Th17/Treg balance in inflammatory bowel diseases. Biomed Pharmacother 141:111931.
  • Chen Q, Zheng Y, Li Y, et al. (2012). The effect of deacetylated gellan gum on aesculin distribution in the posterior segment of the eye after topical administration. Drug Deliv 19:194–201.
  • Chung AS, Ferrara N. (2011). Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27:563–84.
  • Craig DQM, Barker SA, Banning D, Booth SW. (1995). An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. J Int J Pharm 114:103–10.
  • Dmytrenko G, Castro M, Sales MJN. (2017). Denatonium and naringenin promote SCA-9 tumor growth and angiogenesis: participation of arginase. Nutr Cancer 69:780–90.
  • El-Wafaey DI, Nafea OE, Faruk E. (2021). Naringenin alleviates hepatic injury in zinc oxide nanoparticles exposed rats: impact on oxido-inflammatory stress and apoptotic cell death. Toxicol Mech Methods 32:58–66.
  • Francis A, Shetty T, Bhattacharya RJC. (1989). Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis 10:1953–5.
  • Gorain B, Choudhury H, Kundu A, et al. (2014). Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats. Colloids Surf B Biointerfaces 115:286–94.
  • Guan M, Zeng X, Shi R, et al. (2021). Aerosolization performance, antitussive effect and local toxicity of naringenin-hydroxypropyl-β-cyclodextrin inhalation solution for pulmonary delivery. AAPS PharmSciTech 22:20.
  • Han B, Tang H, Liang Q, et al. (2021). Preparation of long-acting microspheres loaded with octreotide for the treatment of portal hypertensive. Drug Deliv 28:719–32.
  • Han KY, Chang JH, Azar DT. (2019). MMP14-containing exosomes cleave VEGFR1 and promote VEGFA-induced migration and proliferation of vascular endothelial cells. Invest Ophthalmol Vis Sci 60:2321–9.
  • Han KY, Chang JH, Lee H, Azar DT. (2016). Proangiogenic interactions of vascular endothelial MMP14 with VEGF receptor 1 in VEGFA-mediated corneal angiogenesis. Invest Ophthalmol Vis Sci 57:3313–22.
  • Han KY, Dugas-Ford J, Lee H, et al. (2015). MMP14 cleavage of VEGFR1 in the cornea leads to a VEGF-Trap antiangiogenic effect. Invest Ophthalmol Vis Sci 56:5450–6.
  • Hu R, Liu S, Shen W, et al. (2021). Study on the inhibitory effects of naringenin-loaded nanostructured lipid carriers against nonalcoholic fatty liver disease. J Biomed Nanotechnol 17:942–51.
  • Irani YD, Scotney PD, Klebe S, et al. (2017). An anti-VEGF-B antibody fragment induces regression of pre-existing blood vessels in the rat cornea. Invest Ophthalmol Vis Sci 58:3404–13.
  • Kalam M, Alshamsan A, Aljuffali I, et al. (2016). Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination. Drug Deliv 23:896–907.
  • Kassaee SN, Mahboobian MM. (2021). Besifloxacin-loaded ocular nanoemulsions: design, formulation and efficacy evaluation. Drug Deliv Transl Res 12:229–39.
  • Lee P, Wang CC, Adamis AP. (1998). Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43:245–69.
  • Li H, Pan T, Cui Y, et al. (2016). Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique. Int J Nanomedicine 11:3777–88.
  • Li Q, Wang Y, Zhang L, et al. (2016). Naringenin exerts anti-angiogenic effects in human endothelial cells: involvement of ERRα/VEGF/KDR signaling pathway. Fitoterapia 111:78–86.
  • Li Z, Li J, Zhu L, et al. (2016). Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats. Int J Nanomedicine 11:6135–48.
  • Liarakos VS, Papaconstantinou D, Vergados I, et al. (2014). The effect of subconjunctival ranibizumab on corneal and anterior segment neovascularization: study on an animal model. Eur J Ophthalmol 24:299–308.
  • Lin J, Sun J, Wang Y, et al. (2015). Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbits. J Ocul Pharmacol Ther 31:51–6.
  • Lin J, Wang Y, Ma Y, et al. (2014). Protective effects of naringenin eye drops on N-methyl-N-nitrosourea-induced photoreceptor cell death in rats. Int J Ophthalmol 7:391–6.
  • Liu D, Wu Q, Zhu Y, et al. (2019). Co-delivery of metformin and levofloxacin hydrochloride using biodegradable thermosensitive hydrogel for the treatment of corneal neovascularization. Drug Deliv 26:522–31.
  • Liu Z, Zhang X, Wu H, et al. (2011). Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo. Drug Dev Ind Pharm 37:475–81.
  • Miles EA, Calder PC. (2021). Effects of citrus fruit juices and their bioactive components on inflammation and immunity: a narrative review. Front Immunol 12:712608.
  • Nicholas MP, Mysore N. (2021). Corneal neovascularization. Exp Eye Res 202:108363.
  • Oguido A, Hohmann MSN, Pinho-Ribeiro FA, et al. (2017). Naringenin eye drops inhibit corneal neovascularization by anti-inflammatory and antioxidant mechanisms. Invest Ophthalmol Vis Sci 58:5764–76.
  • Pafumi I, Festa M, Papacci F, et al. (2017). Naringenin impairs two-pore channel 2 activity and inhibits VEGF-induced. Sci Rep 7:5121.
  • Peiris-Pagès M, Harper S, Bates D, Ramani P. (2010). Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth. J Pathol 222:138–47.
  • Rahman MA, Hussain A, Hussain MS, et al. (2013). Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev Ind Pharm 39:1–19.
  • Shao B, Sun L, Xu N, et al. (2021). Development and evaluation of topical delivery of microemulsions containing adapalene (MEs-Ap) for acne. AAPS PharmSciTech 22:125.
  • Shiratori K, Ohgami K, Ilieva I, et al. (2005). The effects of naringin and naringenin on endotoxin-induced uveitis in rats. J Ocul Pharmacol Ther 21:298–304.
  • Su X, Gao C, Shi F, et al. (2017). A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance. Drug Deliv 24:10–9.
  • Sun M, Chan A, Law S, et al. (2019). Epithelial membrane protein-2 (EMP2) antibody blockade reduces corneal neovascularization in an in vivo model. Invest Ophthalmol Vis Sci 60:245–54.
  • Sun Z, Chen C, Xu F, et al. (2021). Evaluation of the antiviral activity of naringenin, a major constituent of Typha angustifolia, against white spot syndrome virus in crayfish Procambarus clarkii. J Fish Dis 44:1503–13.
  • Wang H, Li X, Yang H, et al. (2020). Nanocomplexes based polyvinylpyrrolidone K-17PF for ocular drug delivery of naringenin. Int J Pharm 578:119133.
  • Wilhelmus KR. (2001). The Draize Eye Test. Survey of Ophthalmology 45:493–515.
  • Zeng F, Wang D, Tian Y, et al. (2021). Nanoemulsion for improving the oral bioavailability of hesperetin: formulation optimization and absorption mechanism. J Pharm Sci 110:2555–61.
  • Zhang P, Liu X, Hu W, et al. (2016). Preparation and evaluation of naringenin-loaded sulfobutylether-beta-cyclodextrin/chitosan nanoparticles for ocular drug delivery. Carbohydr Polym 149:224–30.
  • Zhou T, Miao Y, Li Z, et al. (2020). A comparative ocular pharmacokinetics study of preservative-free latanoprost unit-dose eye drops and a benzalkonium chloride-preserved branded product following topical application to rabbits. J Ocul Pharmacol Ther 36:522–8.
  • Zhu W, Yu A, Wang W, et al. (2008). Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm 360:184–90.